Biomimesys
Meet HCS PHARMA at Forum Labo!
We will be pleased to meet you in Paris from the 28th to 30th of March. Join Thierry DE CATHEU Business Director, Mathieu LAOUENAN Chief Commercial Officer, Paul COUVREUR and Rita HIEN Junior Business Developpers. Read more…
Biomimesys
Happy World Organoid Research Day!
Organoids are three-dimensional structures made of cells, which can be derived from stem cells to mimic the structure and function of real organs. They are useful tools for studying human development, disease modeling, drug screening, Read more…
Biomimesys
HCS Pharma’s series of webinars
Welcome to HCS Pharma series of webinars and please register for free to the ones you want to attend. You will receive the specific Zoom link within a week prior the event.You will learn more Read more…
Biomimesys
It is Blue March for colon cancer testing!
Why is testing important? One million cases of colon cancer are diagnosed each year around the world. Colorectal cancer develops slowly. The tumor, called polyp, appears on the inner wall of the colon and rectum. Read more…
Our news
HCS Pharma will be present at next ELRIG event “Research and Innovation 2023 – Accelerating future DD” in Cambridge on March 29 and 30th
We are pleased to participate in ELRIG event about Research an Innovation 2023 – Accelerating future drug discovery” in Cambridge on March 29 and 30th 2023. Veronique De Conto, our project leader in in vitro Read more…
Biomimesys
Three projects for HCS Pharma with ONCOLille Institute thanks to Plan France Relance and Région Hauts-de-France
The beginning of 2023 is tremendous for HCS Pharma in terms of new oncology-related collaborative R&D projects, with three of them accepted and granted by ANR (Agence Nationale pour la Recherche) through the Plan France Read more…
Biomimesys
HCS Pharma: it is the Brain Week!
The Brain Week is an international event organized simultaneously in about 100 countries and more than 120 cities in France. Its aim is to raise public awareness of the importance of brain research. It is Read more…
Biomimesys
Meet HCS Pharma in BIO-EUROPE Spring 2023!
I will be pleased to be in BIO-Europe Spring in Basel, Switzerland to present BIOMIMESYS, our breakthrough technology and our new results that we have with it. In HCS Pharma, we are reinventing biology with Read more…
Biomimesys
Poster : BIOMIMESYS®, a ready-to-use ECM for Relevant Phenotypic Screening
Poster presented during the SLAS event in San Diego on the 27th and 28th of February 2023. Title: BIOMIMESYS® Hydroscaffold, a ready-to-use organ-specific Extracellular Matrix for Relevant Phenotypic Screening Dr. Nathalie Maubon*, Dr. Véronique De Read more…
biomimesys_custom
We welcome Marina for a PhD thesis on osteoarthritis
After obtaining a Master’s degree in Life Sciences from the “École Pratique des Hautes Études” (Paris Sciences and Letters University) in 2022, Marina Villaverde has just started a PhD thesis. Through the collaboration between the Read more…
biomimesys_liver
Rania joins us to work on a Liver Biochip system
After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with the University of Technology of Compiègne (UTC) using the BIOMIMESYS® Liver hydroscaffold™ and HepG2/C3A (hepatocellular carcinoma cell Read more…
Biomimesys
What are the in vitro alternatives to animal testing in breast cancer research?
2.2 million cases of breast cancer were identified in 2020 by the WHO. This cancer is the first cause of cancer in women. It develops in the glandular lobes or milk ducts. Five subtypes of Read more…
News
We welcome Nathan for a PhD thesis on breast cancer metastasis
After obtaining this Master’s degree in Biology and Health Science at Lille University in 2022, Nathan Laneret has just begun a PhD thesis under the supervision of Pr. RA Toillon and Dr. Nathalie Maubon thanks to Read more…
Biomimesys
BIOMIMESYS® 3D technology in a microfluidic format for pancreatic cancer modeling (France Relance Plan)
It is a pleasure to announce that HCS Pharma has a new collaborative project dealing with Mucins, cancer and drug resistance Team of OncoLille (CANTHER-MUCINE) in the frame of pancreatic cancer, thanks to France Relance Read more…
Biomimesys
HCS Pharma wishes you a happy Valentine’s Day
Because BIOMIMESYS® is made with the heart, he can also love ! BIOMIMESYS® matrix produced by HCS Pharma is a unique groundbreaking 3D cell culture technology which associates both the properties of a solid scaffold Read more…
Biomimesys
New 3D in vitro model of dysbiosis-induced colon cancer thanks to France Relance Plan
It is a pleasure to announce that HCS Pharma has a new collaborative project dealing with Inflammasome et ion channels Team of OncoLille (PHYCELL Lab, INSERM U1003) in the frame of colon cancer, thanks to Read more…
Biomimesys
Retrospective HCS Pharma 2022
We are glad starting a new Year! But nothing better than assessing what happened along the last one to glance back at the road traveled so far… and looking forward to what’s next!